Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
34 participants
OBSERVATIONAL
2022-11-20
2023-04-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* location of the calculi (kidney or bladder)
* type of bladder augmentation with higher rate of urinary calculi and why
* Find risk factors of urinary calculi in bladder augmentation (age, sex, other bladder procedures..)
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ileocystoplasty
Urinary Calculi After Ileocystoplasty in Children
Bladder Augmentation
Bladder Augmentation using bowel loop (ileal or sigmoid loop)
Sigmoidocystoplasty
Urinary Calculi After Sigmoidocystoplasty in Children
Bladder Augmentation
Bladder Augmentation using bowel loop (ileal or sigmoid loop)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bladder Augmentation
Bladder Augmentation using bowel loop (ileal or sigmoid loop)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
0 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
University Hospital, Clermont-Ferrand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Destinval Christelle
M.D.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital, Clermont-Ferrand
Clermont-Ferrand, Auvergne, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M24DC1104
Identifier Type: -
Identifier Source: org_study_id
NCT05861024
Identifier Type: -
Identifier Source: nct_alias